Steven Cohen’s Cardiff Oncology CRDF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-28,385
Closed -$36.9K – 4030
2026
Q2
$36.9K Buy
+28,385
New +$45.1K ﹤0.01% 3827
2025
Q1
– Sell
-508,438
Closed -$2.21M – 2116
2024
Q4
$2.21M Buy
+508,438
New +$1.59M ﹤0.01% 1207
2022
Q1
– Sell
-501,649
Closed -$3.02M – 1203
2021
Q4
$3.02M Buy
+501,649
New +$2.99M 0.01% 764

Other funds holding CRDF

Steven Cohen's CRDF Position: Q3 2026 in Review

Steven Cohen sold out of Cardiff Oncology (CRDF) in Q3 2026, closing a stake of 28,385 shares — an estimated $36.9K sold.

Steven Cohen first reported a position in CRDF in Q4 2021 and held it in 3 quarters. The position peaked at $3.02M in Q4 2021. 75 funds tracked by Wall St. Rank hold CRDF as of Q3 2026.

  • Steven Cohen reported no remaining Cardiff Oncology position as of Q3 2026 after selling out during the quarter.
  • Steven Cohen sold 28,385 Cardiff Oncology shares in Q3 2026, an estimated $36.9K.
  • Steven Cohen first reported a position in Cardiff Oncology in Q4 2021 and held it in 3 quarters.
  • Steven Cohen's Cardiff Oncology position peaked at $3.02M in Q4 2021.
  • 75 funds tracked by Wall St. Rank held Cardiff Oncology as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.